A salen-manganese catalytic free radical scavenger inhibits type 1 diabetes and islet allograft rejection

Diabetes

Volumn 53, Issue 10, 2004, Pages 2574-2580

  Olcott, Angelica P ^a   Tocco, Georges ^b   Tian, Jide ^a   Zekzer, Dan ^a   Fukuto, Jon ^a   Ignarro, Louis ^a   Kaufman, Daniel L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; MANGANESE DERIVATIVE; MANGANESE SALEN CHLORIDE; NITRIC OXIDE; NITROGEN OXIDE; PEROXIDASE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SALEN MANGANESE DERIVATIVE; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL DESTRUCTION; CELL PROTECTION; CELL STRAIN; CELL STRAIN NIT 1; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET ALLOGRAFT; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; CATALYSIS; DIABETES MELLITUS, TYPE 1; ETHYLENEDIAMINES; FEMALE; FREE RADICAL SCAVENGERS; GRAFT REJECTION; ISLETS OF LANGERHANS TRANSPLANTATION; MANGANESE COMPOUNDS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; ORGANOMETALLIC COMPOUNDS;

EID: 4644325195     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.10.2574     Document Type: Article

References (50)

1. Rabinovitch A: Free radicals as mediators of pancreatic islet beta-cell injury in autoimmune diabetes. J Lab Clin Med 119:455-456, 1992
2. Rabinovitch A, Suarez WL, Power RF: Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice. J Lab Clin Med 121:603-607, 1993
3. Corbett JA, Mikhael A, Shimizu J, Frederick K, Misko TP, McDaniel ML, Kanagawa O, Unanue ER: Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A 90:8992-8995, 1993
4. Corbett JA, Wang JL, Misko TP, Zhao W, Hickey WF, McDaniel ML: Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity 15:145-153, 1993
5. Suarez-Pinzon WL, Szabo C, Rabinovitch A: Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet β-cells. Diabetes 46:907-911, 1997
6. Lakey JR, Suarez-Pinzon WL, Strynadka K, Korbutt GS, Rajotte RV, Mabley JG, Szabo C, Rabinovitch A: Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet beta cells. Lab Invest 81:1683-1692, 2001
7. Tiedge M, Lortz S, Munday R, Lenzen S: Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849-855, 1999
8. Suarez-Pinzon WL, Mabley JG, Strynadka K, Power RF, Szabo C, Rabinovitch A: An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. J Autoimmun 16:449-455, 2001
9. Grankvist K, Marklund S, Taljedal IB: Superoxide dismutase is a prophylactic against alloxan diabetes. Nature 294:158-160, 1981
10. Tiedge M, Lortz S, Munday R, Lenzen S: Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47:1578-1585, 1998
11. Thomas PD, Mao GD, Rabinovitch A, Poznansky MJ: Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). Biochem Pharmacol 45: 241-251, 1993
12. MacDonald MJ, Cook JD, Epstein ML, Flowers CH: Large amount of (apo)ferritin in the pancreatic insulin cell and its stimulation by glucose. FASEB J 8:777-781, 1994
13. Iancu TC, Ward RJ, Peters TJ: Ultrastructural changes in the pancreas of carbonyl iron-fed rats. J Pediatr Gastroenterol Nutr 10:95-101, 1990
14. Wink DA, Nims RW, Saavedra JE, Utermahlen WE Jr, Ford PC: The Fenton oxidation mechanism: reactivities of biologically relevant substrates with two oxidizing intermediates differ from those predicted for the hydroxyl radical. Proc Natl Acad Sci U S A 91:6604-6608, 1994
15. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE: Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci U S A 90:8103-8107, 1993
16. Grankvist K, Marklund SL, Taljedal IB: CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 199:393-398, 1981
17. Lenzen S, Drinkgern J, Tiedge M: Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463-466, 1996
18. Kubisch HM, Wang J, Luche R, Carlson E, Bray TM, Epstein CJ, Phillips JP: Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci U S A 91:9956-9959, 1994
19. Kubisch HM, Wang J, Bray TM, Phillips JP: Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic β-cells against oxidative stress. Diabetes 46:1563-1566, 1997
20. Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, Pattou F, Kerr-Conte J, Chroboczek J, Lemarchand P, Halimi S: Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 41:1093-1100, 1998
21. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB: Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101:1811-1820, 1998
22. Bertera S, Crawford ML, Alexander AM, Papworth GD, Watkins SC, Robbins PD, Trucco M: Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 52:387-393, 2003
23. Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, Haskins K: A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 51:347-355, 2002
24. Rabinovitch A, Suarez WL, Power RF: Combination therapy with an antioxidant and a corticosteroid prevents autoimmune diabetes in NOD mice. Life Sci 51:1937-1943, 1992
25. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci U S A 90:9813-9817, 1993
26. O'Brien NC, Charlton B, Cowden WB, Willenborg DO: Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease. J Immunol 167:5904-5912, 2001
27. Doctrow SR, Huffman K, Marcus CB, Tocco G, Malfroy E, Adinolfi CA, Kruk H, Baker K, Lazarowych N, Mascarenhas J, Malfroy B: Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. J Med Chem 45:4549-4558, 2002
28. Sharpe MA, Ollosson R, Stewart VC, Clark JB: Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem J 366:97-107, 2002
29. Malfroy B, Doctrow SR, Orr PL, Tocco G, Fedoseyeva EV, Benichou G: Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. Cell Immunol 177:62-68, 1997
30. Tocco G, Illigens B, Iwamoto Y, Akiyama Y, Benichou GA: Prolongation of skin and heart allograft survival by synthetic catalytic scavengers of reactive oxygen species. Hum Immunol 64:S51, 2003
31. Gonzalez PK, Zhuang J, Doctrow SR, Malfroy B, Benson PF, Menconi MJ, Fink MP: EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther 275:798-806, 1995
32. Doctrow SR, Huffman K, Marcus CB, Musleh W, Bruce A, Baudry M, Malfroy B: Salen-manganese complexes: combined superoxide dismutase/ catalase mimics with broad pharmacological efficacy. Adv Pharmacol 38:247-269, 1997
33. Feelisch M, Ostrowski J, Noack E: On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 14:S13-S22, 1989
34. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S: Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281:419-424, 1992
35. Ioannidis I, de Groot H: Cytotoxicity of nitric oxide in Fu5 rat hepatoma cells: evidence for co-operative action with hydrogen peroxide. Biochem J 296:341-345, 1993
36. Mooradian DL, Hutsell TC, Keefer LK: Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25:674-678, 1995
37. Kurozumi R, Tokuzumi S, Kojima S: Does peroxynitrite involve in the elevation of cellular glutathione induced by sodium nitroprusside (SNP) in RAW 264.7 cells? Biol Pharm Bull 26:1070-1075, 2003
38. Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman D, Mueller R, Arita S, Evans C, Atkinson MA, Mullen Y, Sarvetnick N, Tobin AJ, Lehmann PV, Kaufman DL: Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 2:1348-1353, 1996
39. Baudry M, Etienne S, Bruce A, Palucki M, Jacobsen E, Malfroy B: Salen-manganese complexes are superoxide dismutase-mimics. Biochem Biophys Res Commun 192:964-968, 1993
40. Cunningham JM, Green IC: Cytokines, nitric oxide and insulin secreting cells. Growth Regul 4:173-180, 1994
41. Wink DA, Mitchell JB: Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25:434-456, 1998
42. van der Veen RC, Hinton DR, Incardonna F, Hofman FM: Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 77:1-7, 1997
43. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624, 1990
44. Beckman JS, Chen J, Ischiropoulos H, Crow JP: Oxidative chemistry of peroxynitrite. Methods Enzymol 233:229-240, 1994
45. Delaney CA, Tyrberg B, Bouwens L, Vaghef H, Hellman B, Eizirik DL: Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett 394:300-306, 1996
46. Fukuto JM, Ignarro L: In vivo aspects of nitric oxide (NO) chemistry: does peroxynitrite (-OONO) play a major role in cytotoxicity? Accounts of Chemical Research 30:149-152, 1997
47. Virag L, Szabo E, Gergely P, Szabo C: Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 140-141:113-124, 2003
48. Wink DA, Miranda KM, Espey MG: Cytotoxicity related to oxidative and nitrosative stress by nitric oxide. Exp Biol Med (Maywood) 226:621-623, 2001
49. Kroncke KD: Cysteine-Zn2+ complexes: unique molecular switches for inducible nitric oxide synthase-derived NO. FASEB J 15:2503-2507, 2001
50. Halliwell B: What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411:157-160, 1997